EBOS Group (ASX:EBO, NZE:EBO) reported Wednesday fiscal half-year diluted earnings of AU$0.569 per share, down from AU$0.71 per share a year earlier.
Analysts polled by FactSet expected EPS of AU$0.71.
Revenue for the six months ended Dec. 31, 2024, was AU$5.99 billion, down 9% from AU$6.58 billion a year earlier. Analysts surveyed by FactSet expected AU$5.73 billion in sales revenue.
The healthcare products distributor maintained its guidance of underlying earnings before interest, taxes, depreciation, and amortization of between AU$575 million and AU$600 million for the fiscal year, up 5% to 10% year on year.
The board declared a dividend of NZ$0.57 per share, unchanged from the previously reported period, payable on March 21 to shareholders of record as of Feb. 28.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.